1
|
Arbizu J, Morbelli S, Minoshima S, Barthel H, Kuo P, Van Weehaeghe D, Horner N, Colletti PM, Guedj E. SNMMI Procedure Standard/EANM Practice Guideline for Brain [ 18F]FDG PET Imaging, Version 2.0. J Nucl Med 2024:jnumed.124.268754. [PMID: 39419552 DOI: 10.2967/jnumed.124.268754] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2024] [Accepted: 09/05/2024] [Indexed: 10/19/2024] Open
Abstract
PREAMBLEThe Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and professional organization founded in 1954 to promote the science, technology, and practical application of nuclear medicine. The European Association of Nuclear Medicine (EANM) is a professional nonprofit medical association that facilitates communication worldwide between individuals pursuing clinical and research excellence in nuclear medicine. The EANM was founded in 1985. The EANM was founded in 1985. SNMMI and EANM members are physicians, technologists, and scientists specializing in the research and practice of nuclear medicine.The SNMMI and EANM will periodically define new guidelines for nuclear medicine practice to help advance the science of nuclear medicine and to improve the quality of service to patients throughout the world. Existing practice guidelines will be reviewed for revision or renewal, as appropriate, on their fifth anniversary or sooner, if indicated.Each practice guideline, representing a policy statement by the SNMMI/EANM, has undergone a thorough consensus process in which it has been subjected to extensive review. The SNMMI and EANM recognize that the safe and effective use of diagnostic nuclear medicine imaging requires specific training, skills, and techniques, as described in each document. Reproduction or modification of the published practice guideline by those entities not providing these services is not authorized.These guidelines are an educational tool designed to assist practitioners in providing appropriate care for patients. They are not inflexible rules or requirements of practice and are not intended, nor should they be used, to establish a legal standard of care. For these reasons and those set forth below, both the SNMMI and the EANM caution against the use of these guidelines in litigation in which the clinical decisions of a practitioner are called into question.The ultimate judgment regarding the propriety of any specific procedure or course of action must be made by the physician or medical physicist in light of all the circumstances presented. Thus, there is no implication that an approach differing from the guidelines, standing alone, is below the standard of care. To the contrary, a conscientious practitioner may responsibly adopt a course of action different from that set forth in the guidelines when, in the reasonable judgment of the practitioner, such course of action is indicated by the condition of the patient, limitations of available resources, or advances in knowledge or technology subsequent to publication of the guidelines.The practice of medicine includes both the art and the science of the prevention, diagnosis, alleviation, and treatment of disease. The variety and complexity of human conditions make it impossible to always reach the most appropriate diagnosis or to predict with certainty a particular response to treatment.Therefore, it should be recognized that adherence to these guidelines will not ensure an accurate diagnosis or a successful outcome. All that should be expected is that the practitioner will follow a reasonable course of action based on current knowledge, available resources, and the needs of the patient to deliver effective and safe medical care. The sole purpose of these guidelines is to assist practitioners in achieving this objective.
Collapse
Affiliation(s)
- Javier Arbizu
- Department of Nuclear Medicine, Clinica Universidad de Navarra, University of Navarra, Pamplona, Spain;
| | - Silvia Morbelli
- Nuclear Medicine Unit, Citta'della Scenza e della Salute di Torino, Turin, Italy
- Department of Medical Sciences, University of Turin, Turin, Italy
| | - Satoshi Minoshima
- Department of Radiology and Imaging Sciences, University of Utah, Salt Lake City, Utah
| | - Henryk Barthel
- Department of Nuclear Medicine, Leipzig University Medical Centre, Leipzig, Germany
| | | | | | - Neil Horner
- Atlantic Health System, Morristown, New Jersey, and Icahn School of Medicine at Mount Sinai, New York, New York
| | - Patrick M Colletti
- Department of Radiology and Nuclear Medicine, University of Southern California, Los Angeles, California; and
| | - Eric Guedj
- APHM, CNRS, Centrale Marseille, Institut Fresnel, Timone Hospital, CERIMED, Nuclear Medicine Department, Aix Marseille University, Marseille, France
| |
Collapse
|
2
|
Lee SY, Choe G, Lee SY, Kim NJ, Carandang M, Oh SH, Lee JH, Choi BY. Outcome of cochlear implantation in the worse ear of post-lingual asymmetric hearing loss: elucidation of prognostic markers. Acta Otolaryngol 2021; 141:495-501. [PMID: 33586571 DOI: 10.1080/00016489.2021.1880632] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
BACKGROUND Specific correlations between the outcomes of cochlear implantation (CI) and hearing thresholds of the both ears in post-lingual asymmetric hearing loss (AHL) patients were not clear. AIMS/OBJECTIVES To identify the variables influencing the outcome of CI in post-lingual AHL patients. METHOD We included 18 adult subjects who had CI in the worse ear due to post-lingual AHL with average hearing asymmetry of 36 dB. Speech perception scores were evaluated in the sound field with hearing aid on the better ear before CI, and with the cochlear implant in the worse ear at 3, 6, and 12 months after CI switch-on. RESULTS Average increases in phonetically balanced word score, spondee word score, and everyday sentence score at 12 months from CI switch-on compared with those before CI were 38.9%p, 46.2%p, and 52.4%p, respectively. Multiple linear regression analysis showed that speech perception scores were negatively influenced by age at implantation and hearing threshold difference of both ears (HTD-Both) itself, rather than the worse or better ear hearing thresholds. CONCLUSIONS AND SIGNIFICANCE Post-lingual AHL subjects with high average hearing asymmetry can benefit from CI in the worse ear, while CI outcomes can be adversely influenced by HTD-Both and age at implantation both in the short- and long-term follow-up.
Collapse
Affiliation(s)
- Sang-Youp Lee
- Department of Otolaryngology, Wonkwang University School of Medicine, Wonkwang University Hospital, Iksan, Republic of Korea
| | - Goun Choe
- Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea
| | - Sang-Yeon Lee
- Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea
| | - Namju Justin Kim
- Department of Biological Sciences, Vanderbilt University, Nashville, TN, USA
| | - Marge Carandang
- Department of Otorhinolaryngology-Head and Neck Surgery, Quezon City, Philippines
| | - Seung Ha Oh
- Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea
| | - Jun Ho Lee
- Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea
| | - Byung Yoon Choi
- Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
| |
Collapse
|
3
|
Speck I, Arndt S, Thurow J, Blazhenets G, Aschendorff A, Meyer PT, Frings L. 18F-FDG PET Imaging of the Inferior Colliculus in Asymmetric Hearing Loss. J Nucl Med 2019; 61:418-422. [DOI: 10.2967/jnumed.119.231407] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2019] [Accepted: 08/06/2019] [Indexed: 11/16/2022] Open
|
4
|
Forrest TJ, Desmond TJ, Issa M, Scott PJH, Basura GJ. Evaluating Cholinergic Receptor Expression in Guinea Pig Primary Auditory and Rostral Belt Cortices After Noise Damage Using [ 3H]Scopolamine and [ 18F]Flubatine Autoradiography. Mol Imaging 2019; 18:1536012119848927. [PMID: 31099304 PMCID: PMC6537085 DOI: 10.1177/1536012119848927] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
Abstract
Noise-induced hearing loss leads to anatomic and physiologic changes in primary auditory
cortex (A1) and the adjacent dorsal rostral belt (RB). Since acetylcholine is known to
modulate plasticity in other cortical areas, changes in A1 and RB following noise damage
may be due to changes in cholinergic receptor expression. We used
[3H]scopolamine and [18F]flubatine binding to measure muscarinic
acetylcholine receptor (mAChR) and nicotinic acetylcholine receptor (nAChR) expression,
respectively, in guinea pig A1 and RB 3 weeks following unilateral, left ear noise
exposure, and a temporary threshold shift in hearing. [3H]Scopolamine binding
decreased in right A1 and RB (contralateral to noise) compared to sham controls across all
cortical layers. [18F]Flubatine binding showed a nonsignificant upward trend in
right A1 following noise but only significantly increased in right RB and 2 layers of left
RB (ipsilateral to noise). This selective response may ultimately influence cortical
plasticity and function. The mechanism(s) by which cholinergic receptors are altered
following noise exposure remain unknown. However, these data demonstrate noise exposure
may differentially influence mAChRs that typically populate interneurons in A1 and RB more
than nAChRs that are traditionally located on thalamocortical projections and provide
motivation for cholinergic imaging in clinical patient populations of temporary or
permanent hearing loss.
Collapse
Affiliation(s)
- Taylor J Forrest
- 1 Department of Otolaryngology-Head and Neck Surgery, Kresge Hearing Research Institute University of Michigan, Ann Arbor, MI, USA.,2 Kresge Hearing Research Institute University of Michigan, Ann Arbor, MI, USA.,3 Division of Nuclear Medicine, Department of Radiology, University of Michigan, Ann Arbor MI, USA
| | - Timothy J Desmond
- 3 Division of Nuclear Medicine, Department of Radiology, University of Michigan, Ann Arbor MI, USA
| | - Mohamad Issa
- 1 Department of Otolaryngology-Head and Neck Surgery, Kresge Hearing Research Institute University of Michigan, Ann Arbor, MI, USA.,2 Kresge Hearing Research Institute University of Michigan, Ann Arbor, MI, USA
| | - Peter J H Scott
- 3 Division of Nuclear Medicine, Department of Radiology, University of Michigan, Ann Arbor MI, USA
| | - Gregory J Basura
- 1 Department of Otolaryngology-Head and Neck Surgery, Kresge Hearing Research Institute University of Michigan, Ann Arbor, MI, USA.,2 Kresge Hearing Research Institute University of Michigan, Ann Arbor, MI, USA
| |
Collapse
|
5
|
Micarelli A, Chiaravalloti A, Viziano A, Danieli R, Schillaci O, Alessandrini M. Early cortical metabolic rearrangement related to clinical data in idiopathic sudden sensorineural hearing loss. Hear Res 2017; 350:91-99. [PMID: 28460253 DOI: 10.1016/j.heares.2017.04.011] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/19/2016] [Revised: 04/13/2017] [Accepted: 04/23/2017] [Indexed: 12/11/2022]
Abstract
Results in studies concerning cortical changes in idiopathic sudden sensorineural hearing loss (ISSNHL) are not homogeneous, in particular due to the different neuroimaging techniques implemented and the diverse stages of ISSNHL studied. Considering the recent advances in state-of-the-art positron emission tomography (PET) cameras, the aim of this study was to gain more insight into the neuroanatomical differences associated with the earliest stages of unilateral ISSNHL and clinical-perceptual performance changes. After an audiological examination including the mean auditory threshold (mean AT), mean speech discrimination score (mean SDS) and Tinnitus Handicap Inventory (THI), 14 right-handed ISSNHL patients underwent brain [18F]fluorodeoxyglucose (FDG)-PET within 72 h of the onset of symptoms. When compared to an homogeneous group of 35 healthy subjects by means of statistical parametric mapping, a relative increase in FDG uptake was found in the right superior and medial frontal gyrus as well as in the right anterior cingulate cortex in ISSNHL patients. Conversely, the same group showed a significant relative decrease in FDG uptake in the right middle temporal, precentral and postcentral gyrus as well as in the left posterior cingulate cortex, left lingual, superior, middle temporal and middle frontal gyrus and in the left insula. Regression analysis showed a positive correlation between mean THI and glucose consumption in the right anterior cingulate cortex and a positive correlation between mean SDS and glucose consumption in the left precentral gyrus. The relative changes in FDG uptake found in these brain regions and the positive correlation with mean SDS and THI scores in ISSNHL could possibly highlight new aspects of cerebral rearrangement, contributing to further explain changes in those functions that support speech recognition during the sudden impairment of unilateral auditory input.
Collapse
Affiliation(s)
- Alessandro Micarelli
- University of Rome Tor Vergata, Department of Clinical Sciences and Translational Medicine, Otolaryngology Unit, Italy; University of Rome Tor Vergata, Department of Systems Medicine, Neuroscience Unit, Italy.
| | - Agostino Chiaravalloti
- University of Rome Tor Vergata, Department of Biomedicine and Prevention, Nuclear Medicine Unit, Italy
| | - Andrea Viziano
- University of Rome Tor Vergata, Department of Clinical Sciences and Translational Medicine, Otolaryngology Unit, Italy
| | - Roberta Danieli
- University of Rome Tor Vergata, Department of Biomedicine and Prevention, Nuclear Medicine Unit, Italy
| | - Orazio Schillaci
- University of Rome Tor Vergata, Department of Biomedicine and Prevention, Nuclear Medicine Unit, Italy; IRCCS Neuromed, Pozzilli, Italy
| | - Marco Alessandrini
- University of Rome Tor Vergata, Department of Clinical Sciences and Translational Medicine, Otolaryngology Unit, Italy
| |
Collapse
|